The chemistry and pharmacology of privileged pyrroloquinazolines.

  title={The chemistry and pharmacology of privileged pyrroloquinazolines.},
  author={Bo Chao and Bingbing X. Li and Xiangshu Xiao},
  volume={6 4},
The advent of next-generation sequencing (NGS) technology has plummeted the cost of whole genome sequencing, which has provided a long list of putative drug targets for a variety of diseases ranging from infectious diseases to cancers. The majority of these drug targets are still awaiting high-quality small molecule ligands to validate their therapeutic potential and track their druggability. Screening compound libraries based on privileged scaffolds is an efficient strategy to identify… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Similar Papers

Loading similar papers…